Biotechnology stocks are high-risk, high-reward investments in companies developing novel therapeutics, gene therapies, and biologics. Our AI examines pipeline strength, clinical trial progress, cash runway, and partnership deals from SEC filings to identify the most promising biotech investments.
Best Biotechnology Stocks to Buy in 2026
Top-rated biotechnology stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: May 2026
KRYS
Confidence
82%
NBIX
Confidence
81%
ELMD
Confidence
80%
AMGN
Confidence
79%
NAGE
Confidence
79%
MASI
Confidence
76%
EXEL
Confidence
75%
FTLF
Confidence
74%
RGEN
Confidence
70%
IMCR
Confidence
66%
HALO
Confidence
64%
All Biotechnology Stocks (201)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | STRONG SELL | 97% | View Analysis → |
| NIMU | NON INVASIVE MONITORING SYSTEMS INC /FL/ | STRONG SELL | 96% | View Analysis → |
| IRME | IR-Med, Inc. | STRONG SELL | 96% | View Analysis → |
| ENDV | ENDONOVO THERAPEUTICS, INC. | STRONG SELL | 96% | View Analysis → |
| CFOO | China Foods Holdings Ltd. | STRONG SELL | 96% | View Analysis → |
| ZIVOW | Zivo Bioscience, Inc. | STRONG SELL | 95% | View Analysis → |
| YBGJ | Yubo International Biotech Ltd | STRONG SELL | 95% | View Analysis → |
| TVGNW | Tevogen Bio Holdings Inc. | STRONG SELL | 95% | View Analysis → |
| TIL | Instil Bio, Inc. | STRONG SELL | 95% | View Analysis → |
| TCRG | Cannaisseur Group Inc. | STRONG SELL | 95% | View Analysis → |
| SCLXW | Scilex Holding Co | STRONG SELL | 95% | View Analysis → |
| POSC | POSITRON CORP | STRONG SELL | 95% | View Analysis → |
| PLUR | Pluri Inc. | STRONG SELL | 95% | View Analysis → |
| PLSH | PANACEA LIFE SCIENCES HOLDINGS, INC. | STRONG SELL | 95% | View Analysis → |
| NTRR | NEUTRA CORP. | STRONG SELL | 94% | View Analysis → |
| CRGT | Cortigent, Inc. | SELL | 94% | View Analysis → |
| CPMV | Mosaic ImmunoEngineering Inc. | STRONG SELL | 94% | View Analysis → |
| CEROW | CERO THERAPEUTICS HOLDINGS, INC. | STRONG SELL | 94% | View Analysis → |
| CBDY | Target Group Inc. | STRONG SELL | 94% | View Analysis → |
| BCAB | BioAtla, Inc. | STRONG SELL | 93% | View Analysis → |
| FTII | FutureTech II Acquisition Corp. | STRONG SELL | 93% | View Analysis → |
| EXOZ | EXOZYMES INC. | STRONG SELL | 93% | View Analysis → |
| ESLAW | Estrella Immunopharma, Inc. | STRONG SELL | 93% | View Analysis → |
| ENZN | ENZON PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| CRIS | CURIS INC | STRONG SELL | 92% | View Analysis → |
| ZEOX | Zeo ScientifiX, Inc. | STRONG SELL | 92% | View Analysis → |
| VANI | Vivani Medical, Inc. | STRONG SELL | 92% | View Analysis → |
| VACHW | Voyager Acquisition Corp./Cayman Islands | STRONG SELL | 92% | View Analysis → |
| SNYR | Synergy CHC Corp. | STRONG SELL | 92% | View Analysis → |
| SLDB | Solid Biosciences Inc. | STRONG SELL | 92% | View Analysis → |
| POCI | PRECISION OPTICS CORPORATION, INC. | STRONG SELL | 92% | View Analysis → |
| PHGE | BiomX Inc. | STRONG SELL | 92% | View Analysis → |
| GTHP | GUIDED THERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| GPLB | Green Planet Bio Engineering Co. Ltd. | STRONG SELL | 92% | View Analysis → |
| INKT | MiNK Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| EDIT | Editas Medicine, Inc. | STRONG SELL | 92% | View Analysis → |
| DBVTF | DBV Technologies S.A. | STRONG SELL | 92% | View Analysis → |
| CUBT | Curative Biotechnology Inc | SELL | 92% | View Analysis → |
| CLDWW | Calidi Biotherapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| MGTX | MeiraGTx Holdings plc | STRONG SELL | 91% | View Analysis → |
| DNABW | Ginkgo Bioworks Holdings, Inc. | STRONG SELL | 91% | View Analysis → |
| CVM | CEL SCI CORP | STRONG SELL | 91% | View Analysis → |
| CRDF | Cardiff Oncology, Inc. | STRONG SELL | 91% | View Analysis → |
| TIVC | Tivic Health Systems, Inc. | STRONG SELL | 90% | View Analysis → |
| RAPH | Raphael Pharmaceutical Inc. | STRONG SELL | 90% | View Analysis → |
| OTLK | Outlook Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| NDRA | ENDRA Life Sciences Inc. | STRONG SELL | 90% | View Analysis → |
| LIMNW | Liminatus Pharma, Inc. | STRONG SELL | 90% | View Analysis → |
| NUWE | Nuwellis, Inc. | STRONG SELL | 90% | View Analysis → |
| MGX | Metagenomi Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| FNCH | Finch Therapeutics Group, Inc. | STRONG SELL | 90% | View Analysis → |
| DFTX | Definium Therapeutics, Inc. | SELL | 90% | View Analysis → |
| CV | CapsoVision, Inc | STRONG SELL | 90% | View Analysis → |
| CRBU | Caribou Biosciences, Inc. | SELL | 90% | View Analysis → |
| IBRX | ImmunityBio, Inc. | STRONG SELL | 89% | View Analysis → |
| ENTX | Entera Bio Ltd. | SELL | 89% | View Analysis → |
| VIR | Vir Biotechnology, Inc. | STRONG SELL | 88% | View Analysis → |
| STRO | SUTRO BIOPHARMA, INC. | STRONG SELL | 88% | View Analysis → |
| SNTI | Senti Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| SLXNW | Silexion Therapeutics Corp | STRONG SELL | 88% | View Analysis → |
| SGMO | SANGAMO THERAPEUTICS, INC | STRONG SELL | 88% | View Analysis → |
| RVMDW | Revolution Medicines, Inc. | STRONG SELL | 88% | View Analysis → |
| QTIWW | QT IMAGING HOLDINGS, INC. | STRONG SELL | 88% | View Analysis → |
| OCGN | Ocugen, Inc. | STRONG SELL | 88% | View Analysis → |
| INBX | Inhibrx Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| RGNX | REGENXBIO Inc. | STRONG SELL | 88% | View Analysis → |
| INMB | Inmune Bio, Inc. | SELL | 88% | View Analysis → |
| FATE | FATE THERAPEUTICS INC | SELL | 88% | View Analysis → |
| ELUT | ELUTIA INC. | SELL | 88% | View Analysis → |
| ECOR | electroCore, Inc. | SELL | 88% | View Analysis → |
| CRLBF | Cresco Labs Inc. | SELL | 88% | View Analysis → |
| SRZNW | Surrozen, Inc./DE | STRONG SELL | 87% | View Analysis → |
| PLX | Protalix BioTherapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| DYAI | DYADIC INTERNATIONAL INC | SELL | 87% | View Analysis → |
| CADL | Candel Therapeutics, Inc. | SELL | 87% | View Analysis → |
| CABA | Cabaletta Bio, Inc. | SELL | 87% | View Analysis → |
| LXEO | Lexeo Therapeutics, Inc. | SELL | 86% | View Analysis → |
| INTS | INTENSITY THERAPEUTICS, INC. | SELL | 86% | View Analysis → |
| ESMC | ESCALON MEDICAL CORP | SELL | 86% | View Analysis → |
| DNLI | Denali Therapeutics Inc. | SELL | 86% | View Analysis → |
| CURLF | Curaleaf Holdings, Inc. | SELL | 86% | View Analysis → |
| CHUC | Charlie's Holdings, Inc. | SELL | 86% | View Analysis → |
| XFOR | X4 Pharmaceuticals, Inc | STRONG SELL | 85% | View Analysis → |
| VYGR | Voyager Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| VIVS | VivoSim Labs, INC. | STRONG SELL | 85% | View Analysis → |
| TLRY | Tilray Brands, Inc. | STRONG SELL | 85% | View Analysis → |
| STEX | Streamex Corp. | STRONG SELL | 85% | View Analysis → |
| PTHS | Pelthos Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| PROK | PROKIDNEY CORP. | STRONG SELL | 85% | View Analysis → |
| PCVX | Vaxcyte, Inc. | STRONG SELL | 85% | View Analysis → |
| JUSHF | Jushi Holdings Inc. | STRONG SELL | 85% | View Analysis → |
| NRXS | Neuraxis, INC | STRONG SELL | 85% | View Analysis → |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | SELL | 85% | View Analysis → |
| FDMT | 4D Molecular Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CWLXF | C21 Investments Inc. | SELL | 85% | View Analysis → |
| CMPX | Compass Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CHRS | Coherus Oncology, Inc. | SELL | 85% | View Analysis → |
| CGEM | Cullinan Therapeutics, Inc. | SELL | 85% | View Analysis → |
| MAZE | Maze Therapeutics, Inc. | SELL | 84% | View Analysis → |
| IRIX | IRIDEX CORP | SELL | 84% | View Analysis → |
| IPHYF | Innate Pharma SA | SELL | 84% | View Analysis → |
| GHBWF | Glass House Brands Inc. | SELL | 84% | View Analysis → |
| ENGNW | enGene Holdings Inc. | SELL | 84% | View Analysis → |
| CYAND | CYANOTECH CORP | SELL | 84% | View Analysis → |
| CGTX | COGNITION THERAPEUTICS INC | SELL | 84% | View Analysis → |
| CCCC | C4 Therapeutics, Inc. | SELL | 84% | View Analysis → |
| LEEEF | Leef Brands Inc. | STRONG SELL | 83% | View Analysis → |
| HUMAW | Humacyte, Inc. | STRONG SELL | 83% | View Analysis → |
| EVAX | Evaxion A/S | SELL | 83% | View Analysis → |
| CGON | CG Oncology, Inc. | SELL | 83% | View Analysis → |
| DTIL | PRECISION BIOSCIENCES INC | SELL | 82% | View Analysis → |
| KRYS | Krystal Biotech, Inc. | BUY | 82% | View Analysis → |
| NXL | Nexalin Technology, Inc. | STRONG SELL | 82% | View Analysis → |
| JSPRW | Jasper Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| NMRA | Neumora Therapeutics, Inc. | SELL | 82% | View Analysis → |
| NBIX | NEUROCRINE BIOSCIENCES INC | BUY | 81% | View Analysis → |
| PASG | Passage BIO, Inc. | STRONG SELL | 80% | View Analysis → |
| KOD | Kodiak Sciences Inc. | SELL | 80% | View Analysis → |
| ELMD | Electromed, Inc. | BUY | 80% | View Analysis → |
| CBLL | Ceribell, Inc. | SELL | 80% | View Analysis → |
| AMGN | AMGEN INC | BUY | 79% | View Analysis → |
| NAGE | Niagen Bioscience, Inc. | BUY | 79% | View Analysis → |
| FENC | FENNEC PHARMACEUTICALS INC. | SELL | 79% | View Analysis → |
| VOR | Vor Biopharma Inc. | SELL | 78% | View Analysis → |
| TNYA | Tenaya Therapeutics, Inc. | SELL | 78% | View Analysis → |
| SRRK | Scholar Rock Holding Corp | SELL | 78% | View Analysis → |
| SABSW | SAB Biotherapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| PRME | Prime Medicine, Inc. | STRONG SELL | 78% | View Analysis → |
| PMCB | PharmaCyte Biotech, Inc. | SELL | 78% | View Analysis → |
| IMA | ImageneBio, Inc. | SELL | 78% | View Analysis → |
| HYEX | HEALTHY EXTRACTS INC. | SELL | 78% | View Analysis → |
| MTEX | MANNATECH INC | SELL | 78% | View Analysis → |
| IVVD | Invivyd, Inc. | SELL | 78% | View Analysis → |
| IPSC | Century Therapeutics, Inc. | SELL | 78% | View Analysis → |
| CRON | Cronos Group Inc. | SELL | 78% | View Analysis → |
| LONA | LeonaBio, Inc. | SELL | 77% | View Analysis → |
| MASI | MASIMO CORP | BUY | 76% | View Analysis → |
| MRNA | Moderna, Inc. | SELL | 76% | View Analysis → |
| ITGR | Integer Holdings Corp | SELL | 76% | View Analysis → |
| LCTX | Lineage Cell Therapeutics, Inc. | SELL | 76% | View Analysis → |
| CSBR | CHAMPIONS ONCOLOGY, INC. | SELL | 76% | View Analysis → |
| EXEL | EXELIXIS, INC. | BUY | 75% | View Analysis → |
| AXGN | Axogen, Inc. | SELL | 75% | View Analysis → |
| TECH | BIO-TECHNE Corp | HOLD | 75% | View Analysis → |
| MEHA | Functional Brands Inc. | SELL | 75% | View Analysis → |
| ADPT | Adaptive Biotechnologies Corp | HOLD | 74% | View Analysis → |
| OM | Outset Medical, Inc. | SELL | 74% | View Analysis → |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | SELL | 74% | View Analysis → |
| LENZ | LENZ Therapeutics, Inc. | SELL | 74% | View Analysis → |
| KYTX | Kyverna Therapeutics, Inc. | SELL | 74% | View Analysis → |
| REPL | Replimune Group, Inc. | STRONG SELL | 74% | View Analysis → |
| MRMD | MARIMED INC. | SELL | 74% | View Analysis → |
| FTLF | FITLIFE BRANDS, INC. | BUY | 74% | View Analysis → |
| CNMD | CONMED Corp | SELL | 74% | View Analysis → |
| KYMR | Kymera Therapeutics, Inc. | SELL | 73% | View Analysis → |
| CRSP | CRISPR Therapeutics AG | SELL | 72% | View Analysis → |
| TWST | Twist Bioscience Corp | HOLD | 72% | View Analysis → |
| RXRX | RECURSION PHARMACEUTICALS, INC. | SELL | 72% | View Analysis → |
| RLAY | Relay Therapeutics, Inc. | SELL | 72% | View Analysis → |
| BIIB | BIOGEN INC. | HOLD | 72% | View Analysis → |
| ZURA | Zura Bio Ltd | HOLD | 72% | View Analysis → |
| VASO | VASO Corp | HOLD | 72% | View Analysis → |
| TSHA | Taysha Gene Therapies, Inc. | SELL | 72% | View Analysis → |
| STXS | Stereotaxis, Inc. | SELL | 72% | View Analysis → |
| SANA | Sana Biotechnology, Inc. | SELL | 72% | View Analysis → |
| HYPR | Hyperfine, Inc. | SELL | 72% | View Analysis → |
| GLUC | Glucose Health, Inc. | STRONG SELL | 72% | View Analysis → |
| RGEN | REPLIGEN CORP | BUY | 70% | View Analysis → |
| FONR | FONAR CORP | HOLD | 70% | View Analysis → |
| IKT | Inhibikase Therapeutics, Inc. | SELL | 69% | View Analysis → |
| GLUE | Monte Rosa Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| TMDX | TransMedics Group, Inc. | HOLD | 68% | View Analysis → |
| USNA | USANA HEALTH SCIENCES INC | SELL | 68% | View Analysis → |
| TARA | Protara Therapeutics, Inc. | SELL | 68% | View Analysis → |
| PALI | PALISADE BIO, INC. | SELL | 68% | View Analysis → |
| LIVN | LivaNova PLC | HOLD | 68% | View Analysis → |
| NVAX | NOVAVAX INC | SELL | 67% | View Analysis → |
| IMVT | Immunovant, Inc. | SELL | 66% | View Analysis → |
| IMCR | Immunocore Holdings plc | BUY | 66% | View Analysis → |
| VCEL | Vericel Corp | HOLD | 65% | View Analysis → |
| TECX | Tectonic Therapeutic, Inc. | HOLD | 65% | View Analysis → |
| HCIL | Hongchang International Co., Ltd | SELL | 64% | View Analysis → |
| HALO | HALOZYME THERAPEUTICS, INC. | BUY | 64% | View Analysis → |
| TCNNF | Trulieve Cannabis Corp. | HOLD | 62% | View Analysis → |
| TARS | Tarsus Pharmaceuticals, Inc. | HOLD | 62% | View Analysis → |
| KLRS | Kalaris Therapeutics, Inc. | SELL | 60% | View Analysis → |
| INAB | IN8BIO, INC. | SELL | 58% | View Analysis → |
| TCRX | TScan Therapeutics, Inc. | SELL | 50% | View Analysis → |
| CGC | Canopy Growth Corp | SELL | 49% | View Analysis → |
| VXRT | Vaxart, Inc. | HOLD | 48% | View Analysis → |
| CGEN | COMPUGEN LTD | HOLD | 47% | View Analysis → |
| CLLS | Cellectis S.A. | SELL | 44% | View Analysis → |
| INMD | InMode Ltd. | HOLD | 42% | View Analysis → |
| EIKN | Eikon Therapeutics, Inc. | HOLD | 41% | View Analysis → |
| EDAP | EDAP TMS SA | HOLD | 39% | View Analysis → |
| CRDL | Cardiol Therapeutics Inc. | HOLD | 39% | View Analysis → |
| RGC | Regencell Bioscience Holdings Ltd | SELL | 22% | View Analysis → |
| MOLN | MOLECULAR PARTNERS AG | HOLD | 18% | View Analysis → |
| MDWD | MediWound Ltd. | SELL | 15% | View Analysis → |
| MEOBF | MESOBLAST LTD | HOLD | 5% | View Analysis → |
Frequently Asked Questions: Biotechnology Stocks
What are the best biotechnology stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 11 biotechnology stocks have Buy or Strong Buy ratings in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which biotechnology stocks have Strong Buy ratings?
Currently, 0 biotechnology stocks have a Strong Buy rating from our AI analysis. Strong Buy indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze biotechnology stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Biotechnology stocks with 80%+ confidence have the most reliable ratings.
Should I invest in biotechnology stocks in 2026?
Our AI analysis shows 11 Buy ratings vs 168 Sell ratings in the biotechnology sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are biotechnology stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most biotechnology stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for biotechnology stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.
Compare Top Biotechnology Stocks
Part of: 💊 Healthcare Sector